This Bull Market Indicator called NVDA at $116

Every now and again we find an investment idea so incredible we can’t help but share. And today is one of those rare days… Except, today we won't be giving you insight on any one particular stock… But rather, insight on a revolutionary new stock picking indicator… In fact, within the last year, this indicator has become famous for a multitude of reasons… But one of the biggest was because of the buy signal it issued on October 18th, 2022. In fact, on that very day, it said to buy NVDA at $116.37… Anyone who did would be sitting on a tremendously large return today… But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run…

All you have to do is follow this link here

Gene Wickes Biography and Net Worth

Insider of Willis Towers Watson Public

Gene Wickes is Head of Benefits Delivery & Administration as well as Head of the Business Review Team at WTW.

Gene has held many different positions at WTW and predecessor companies, including both geography and segment roles. Gene has been a consulting actuary throughout his professional career.

He began his career at Towers Perrin before moving to Watson Wyatt. He was a member of the merger teams for both the Towers Watson and WTW mergers. Gene holds multiple degrees in mathematics and economics from Brigham Young University.

What is Gene H. Wickes' net worth?: The estimated net worth of Gene H. Wickes is at least $22.37 million as of September 7th, 2022. Mr. Wickes owns 72,475 shares of Willis Towers Watson Public stock worth more than $22,366,510 as of November 21st. This net worth evaluation does not reflect any other assets that Mr. Wickes may own. Learn More about Gene H. Wickes' net worth.
How do I contact Gene H. Wickes?: The corporate mailing address for Mr. Wickes and other Willis Towers Watson Public executives is C/O WILLIS GROUP LIMITED 51 LIME STREET, LONDON X0, EC3M 7DQ. Willis Towers Watson Public can also be reached via phone at 442031246000 and via email at [email protected]. Learn More on Gene H. Wickes' contact information.
Has Gene H. Wickes been buying or selling shares of Willis Towers Watson Public?: Gene H. Wickes has not been actively trading shares of Willis Towers Watson Public during the past quarter. Most recently, Gene H. Wickes sold 13,925 shares of the business's stock in a transaction on Wednesday, September 7th. The shares were sold at an average price of $207.45, for a transaction totalling $2,888,741.25. Following the completion of the sale, the insider now directly owns 72,475 shares of the company's stock, valued at $15,034,938.75. Learn More on Gene H. Wickes' trading history.
Who are Willis Towers Watson Public's active insiders?: Willis Towers Watson Public's insider roster includes Anne Bodnar (Insider), Julie Gebauer (Insider), Carl Hess (CEO), Andrew Krasner (CFO), Brendan Oneill (Director), and Gene Wickes (Insider). Learn More on Willis Towers Watson Public's active insiders.
Are insiders buying or selling shares of Willis Towers Watson Public?: In the last year, insiders at the sold shares 1 times. They sold a total of 1,100 shares worth more than $299,343.00. The most recent insider tranaction occured on March, 1st when CFO Andrew Jay Krasner sold 1,100 shares worth more than $299,343.00. Insiders at Willis Towers Watson Public own 0.2% of the company. Learn More about insider trades at Willis Towers Watson Public.
Information on this page was last updated on 3/1/2024.

Gene H. Wickes Insider Trading History at Willis Towers Watson Public

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/7/2022	Sell	13,925	$207.45	$2,888,741.25	72,475
8/26/2022	Sell	10,000	$209.47	$2,094,700.00	72,475
8/17/2022	Sell	398	$220.00	$87,560.00	72,475

Gene H. Wickes Buying and Selling Activity at Willis Towers Watson Public

Willis Towers Watson Public Company Overview

Willis Towers Watson Public Limited Company operates as an advisory, broking, and solutions company worldwide. It operates through two segments: Health, Wealth & Career and Risk & Broking. The company offers strategy and design consulting, plan management service and support, broking and administration services for health, wellbeing, and other group benefit program, including medical, dental, disability, life, voluntary benefits and other coverages; actuarial support, plan design, and administrative services for pension and retirement savings plans; retirement consulting services and solutions; and integrated solutions that consists of investment discretionary management, pension administration, core actuarial, and communication and change management assistance services. It also provides advice, data, software, and products to address clients' total rewards and talent issues; and risk advice, insurance brokerage, and consulting services in the areas of property and casualty, affinity, risk and analytics, aerospace, construction, global markets direct & facultative, financial, executive and professional risks, financial solutions, crisis management, surety, marine, and natural resources. In addition, the company offers integrated solutions that consists of investment discretionary management, pension administration, core actuarial, and communication and change management assistance services; and software and technology, risk and capital management, products and product pricing, financial and regulatory reporting, financial and capital modeling, M&A, outsourcing, and business management services. The company was formerly known as Willis Group Holdings Public Limited Company and changed its name to Willis Towers Watson Public Limited Company in January 2016. Willis Towers Watson Public Limited Company was founded in 1828 and is based in London, the United Kingdom.

Today's Range

Now: $308.61

$307.32

$309.06

50 Day Range

MA: $297.59

$287.99

$317.41

2 Week Range

Now: $308.61

$234.01

$320.77

Volume

830,477 shs

Average Volume

692,898 shs

Market Capitalization

$31.08 billion

P/E Ratio

N/A

Dividend Yield

1.14%

Beta

0.73